Back to Categories

PARP inhibitor Medicines in UAE

12 medicines available

About PARP inhibitor Medicines

This page lists all PARP inhibitor medicines available in UAE pharmacies. Click on any medicine name to view detailed information including uses, dosage, side effects, and availability.

Complete List of PARP inhibitor Medicines

Brand: ZEJULA | Strength: 100 mg | Form: Capsules
Class: | PARP inhibitor Use: | Treatment of adult patients with recurrent ovarian cancer, including those with BRCA mutations, who have received 1 or more prior lines of chemotherapy Adult dose: |...
Brand: ZEJULA | Strength: 100 mg | Form: Capsules
Class: | PARP inhibitor Use: | Treatment of adult patients with recurrent ovarian, fallopian tube, or primary peritoneal cancer who have responded to platinum-based chemotherapy Adult dose: | 300 ...
Brand: ZEJULA | Strength: 100 mg | Form: Tablets
Class: | PARP inhibitor Use: | Treatment of adult patients with recurrent ovarian cancer, including those with BRCA mutation, following response to platinum-based chemotherapy Adult dose: | 300 mg...
Brand: ZEJULA | Strength: 100 mg | Form: Tablets
Class: | PARP inhibitor Use: | Treatment of adult patients with recurrent ovarian cancer, including those with BRCA mutations, following response to platinum-based chemotherapy. Adult dose: | 300 ...
Brand: LYNPARZA | Strength: 100 mg | Form: Tablets
Class: | PARP inhibitor Use: | Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated advanced ovarian cancer, breast cancer, pancreatic cancer, and prostate can...
Brand: LYNPARZA | Strength: 150 mg | Form: Tablets
Class: | PARP inhibitor Use: | Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated advanced ovarian cancer, breast cancer, pancreatic cancer, and prostate can...
Brand: LYNPARZA | Strength: 50 mg | Form: Capsules
Class: | PARP inhibitor Use: | Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated advanced ovarian cancer, breast cancer, pancreatic cancer, and prostate can...
Brand: TALZENNA | Strength: 0.25 mg | Form: Capsules
Class:| PARP inhibitor Use:| Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated HER2-negative locally advanced or metastatic breast cancer Adult dose:| 1 m...
Brand: TALZENNA | Strength: 1 mg | Form: Capsules
Class:| PARP inhibitor Use:| Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated, HER2-negative locally advanced or metastatic breast cancer Adult dose:| 1 ...
Brand: TALZENNA | Strength: 0.1 | Form: Hard Hypromellose - Capsule
Class:| PARP (Poly ADP-Ribose Polymerase) inhibitor Use:| Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated HER2-negative locally advanced or metastatic bre...
Brand: TALZENNA | Strength: 0.35 mg/1 Capsule | Form: Hard Hypromellose - Capsule
Class:| PARP inhibitor Use:| Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated HER2-negative locally advanced or metastatic breast cancer. Adult dose:| 0....
Brand: TALZENNA | Strength: 0.5 mg/1 Capsule | Form: Capsules
Class:| PARP inhibitor Use:| Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated HER2-negative locally advanced or metastatic breast cancer. Adult dose:| 1 ...
Browse All Categories Search Medicines